SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
48 hedge funds and large institutions have $47.9M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
13
Reduced
8
Closed
6
Calls
$1.04M
Puts
–
Net Calls
+$1.04M
Net Calls Change
+$212K
Top Buyers
1 |
DTC
1
Deep Track Capital
Greenwich,
Connecticut
|
$3.27M |
2 |
CA
2
CHI Advisors
New York
|
$5.12M |
3 |
APM
3
Avidity Partners Management
Dallas,
Texas
|
$6.25M |
4 |
4
BlackRock
New York
|
$971K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.09M |